Impaired cognition in narcolepsy: clinical and neurobiological perspectives

被引:0
|
作者
Cano, Christopher A. [1 ,2 ]
Harel, Brian T. [3 ]
Scammell, Thomas E. [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Neurol, 330 Brookline Ave, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Neurol, Boston, MA USA
[3] Takeda Dev Ctr Amer Inc, Neurosci Therapeut Area Unit, Cambridge, MA USA
关键词
narcolepsy; orexin; hypocretin; cognition; attention; executive function; memory; arousal; CORTICAL ACETYLCHOLINE-RELEASE; PREFRONTAL CORTEX; HYPOCRETIN-OREXIN; SUSTAINED ATTENTION; EXECUTIVE FUNCTIONS; MEMORY IMPAIRMENT; SODIUM OXYBATE; DOPAMINE; PERFORMANCE; TASK;
D O I
10.1093/sleep/zsae150
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In addition to well-known symptoms such as sleepiness and cataplexy, many people with narcolepsy have impaired cognition, reporting inattention, poor memory, and other concerns. Unfortunately, research on cognition in narcolepsy has been limited. Strong evidence demonstrates difficulties with sustained attention, but evidence for executive dysfunction and impaired memory is mixed. Animal research provides some insights into how loss of the orexin neurons in narcolepsy type 1 may give rise to impaired cognition via dysfunction of the prefrontal cortex, and cholinergic and monoaminergic systems. This paper reviews some of these clinical and preclinical findings, provides a neurobiological framework to understand these deficits, and highlights some of the many key unanswered questions.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Finding a home: Developmental and neurobiological perspectives on cultural models
    Bonn, Gregory
    ASIAN JOURNAL OF SOCIAL PSYCHOLOGY, 2020, 23 (02) : 163 - 173
  • [32] Hypocretin Ligand Deficiency in Narcolepsy: Recent Basic and Clinical Insights
    Cayde Ritchie
    Masashi Okuro
    Takashi Kanbayashi
    Seiji Nishino
    Current Neurology and Neuroscience Reports, 2010, 10 : 180 - 189
  • [33] Cotinine, a neuroactive metabolite of nicotine: Potential for treating disorders of impaired cognition
    Terry, AV
    Hernandez, CM
    Hohnadel, EJ
    Bouchard, KP
    Buccafusco, JJ
    CNS DRUG REVIEWS, 2005, 11 (03): : 229 - 252
  • [34] Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels
    Nakamura, Masaki
    Kanbayashi, Takashi
    Sugiura, Tatsuki
    Inoue, Yuichi
    JOURNAL OF SLEEP RESEARCH, 2011, 20 (01) : 45 - 49
  • [35] Neuroimaging in Narcolepsy and Idiopathic Hypersomnia: from Neural Correlates to Clinical Practice
    Gool, Jari K.
    Cross, Nathan
    Fronczek, Rolf
    Lammers, Gert Jan
    van der Werf, Ysbrand D.
    Thien Thanh Dang-Vu
    CURRENT SLEEP MEDICINE REPORTS, 2020, 6 (04) : 251 - 266
  • [36] Neurobiological and Neuropsychological Perspectives on Substance Dependence
    Martin-Soelch, C.
    ZEITSCHRIFT FUR NEUROPSYCHOLOGIE, 2010, 21 (03) : 153 - 166
  • [37] Neurobiological Approach of Catatonia and Treatment Perspectives
    Ellul, Pierre
    Choucha, Walid
    FRONTIERS IN PSYCHIATRY, 2015, 6
  • [38] Current understandings about cognition and the neurobiological correlates in schizophrenia
    Kar, Sujita Kumar
    Jain, Meha
    JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2016, 7 (03) : 412 - 418
  • [39] Clinical and practical considerations in the pharmacologic management of narcolepsy
    Thorpy, Michael J.
    Dauvilliers, Yves
    SLEEP MEDICINE, 2015, 16 (01) : 9 - 18
  • [40] Narcolepsy: etiology, clinical features, diagnosis and treatment
    Zawilska, Jolanta B.
    Woldan-Tambor, Agata
    Plocka, Anna
    Kuzajska, Katarzyna
    Wojcieszak, Jakub
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2012, 66 : 771 - 786